Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.

This study has been completed.
Information provided by:
Takeda Identifier:
First received: October 28, 2005
Last updated: June 2, 2010
Last verified: June 2010